At this point in time revenues generated from the P&G relationship have been slower and smaller than anybody probably envisaged. At this point in time its not the company maker everybody envisaged. Maybe over time it may be. But for now, it aint.
For those of us with medium term timeframes the focus is on the P&G revenues giving the company capacity to subsidize more meaningful projects such as Bodyguard & Surface Hygiene. Surely they are the company makers going forward - at least those products arent subject to voodoo marketing and economics (such as deprivation marketing).
Am I wrong in saying that I dont think we will be seeing revenues in the tens of millions until at least 2020? I mean, if Bodyguard and Surface Hygiene are real goers, its going to take time to scale up production, distribution and win market share.
- Forums
- ASX - By Stock
- WFL
- Ann: Director Retirement
Ann: Director Retirement, page-64
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online